•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 

A09562 Summary:

BILL NOA09562
 
SAME ASSAME AS S06999
 
SPONSORGottfried
 
COSPNSRLupardo, Dinowitz, Paulin, Hevesi, Blake, Brindisi, Cook, Ortiz, Russell, Sepulveda, Simon, Skartados, Skoufis, Zebrowski, Abinanti, Cahill, Rosenthal, Peoples-Stokes, McDonald
 
MLTSPNSR
 
Amd §3360, Pub Health L
 
Amends the dosing limitations and medical conditions permitting the use of medical marihuana.
Go to top

A09562 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A9562
 
SPONSOR: Gottfried
  TITLE OF BILL: An act to amend the public health law, in relation to dosing limitations and medical conditions permitting the medical use of marihuana   PURPOSE: To allow medical marihuana to be used to treat additional diseases and conditions and to remove the limit of ten milligrams of tetrahydrocanna- binol per dose of medical marihuana   SUMMARY OF SPECIFIC PROVISIONS: Section 1: Amends subdivision 15 of § 3360 of the Public Health Law to remove the limit of ten milligrams of tetrahydrocannabinol per dose of medical marihuana. Section 2: Amends subdivision 7 of § 3360 of the Public Health Law by adding the following to the list of diseases and conditions treatable by use of medical marihuana: Alzheimer's disease, traumatic brain injury, dystonia, muscular dystrophy, wasting syndrome, post traumatic stress disorder, rheumatoid arthritis and lupus. Section 3: Effective date.   JUSTIFICATION: These conditions were included in the bill that initially passed the Assembly and was expected to pass the Senate, but were deleted from the final bill. Expanding the list would offer critical treatment options to more patients whose lives could be improved by medical marihuana. Some of these conditions, such as PTSD and muscular dystrophy, are treated with medical marihuana in other states. Other conditions are subject to ongo- ing research, such as January 2016 findings from Israel showing poten- tial benefits for Alzheimer's patients. (http://www.ncbi.nlm.nih.gov/pubmed/26757043) It is questionable whether the law ought to limit the eligible condi- tions at all. The law does not list eligible conditions for other drugs. The medical marihuana law also places a limit of ten milligrams of tetrahydrocannabinol (THC) per dose of medical marihuana. For some patients, low THC products may be appropriate; for others, higher THC may be. This decision should be made by a patient and his or her doctor and not based on an arbitrary statute. The limit in the law has little effect, because there is no limit on how many doses a patient may use at a time.   PRIOR LEGISLATIVE HISTORY: New bill.   FISCAL IMPLICATIONS: None.   EFFECTIVE DATE: Immediately.
Go to top